These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19075522)

  • 1. Action potential alternans in the right ventricular outflow tract in a patient with asymptomatic Brugada syndrome.
    Kofune M; Watanabe I; Ashino S; Ohkubo K; Okumura Y; Kofune T; Nakai T; Hirayama A
    Circ J; 2009 Mar; 73(3):580-3. PubMed ID: 19075522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in arrhythmogenicity between the canine right ventricular outflow tract and anteroinferior right ventricle in a model of Brugada syndrome.
    Morita H; Zipes DP; Morita ST; Wu J
    Heart Rhythm; 2007 Jan; 4(1):66-74. PubMed ID: 17198993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient.
    Ohkubo K; Watanabe I; Okumura Y; Yamada T; Masaki R; Kofune T; Oshikawa N; Kasamaki Y; Saito S; Ozawa Y; Kanmatsuse K
    Pacing Clin Electrophysiol; 2003 Sep; 26(9):1900-3. PubMed ID: 12930508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.
    Kakihara J; Takagi M; Hayashi Y; Tatsumi H; Doi A; Yoshiyama M
    Heart Vessels; 2017 Sep; 32(9):1151-1159. PubMed ID: 28364267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of quinidine on the action potential duration restitution property in the right ventricular outflow tract in patients with brugada syndrome.
    Ashino S; Watanabe I; Kofune M; Nagashima K; Ohkubo K; Okumura Y; Mano H; Nakai T; Kunimoto S; Kasamaki Y; Hirayama A
    Circ J; 2011; 75(9):2080-6. PubMed ID: 21737956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface ECG characteristics of ventricular tachyarrhythmias before degeneration into ventricular fibrillation in patients with Brugada-type ECG.
    Ohkubo K; Watanabe I; Okumura Y; Ashino S; Kofune M; Ohta M; Nakai T; Kunimoto S; Kasamaki Y; Hirayama A
    Int Heart J; 2009 Jul; 50(4):477-87. PubMed ID: 19609052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndrome.
    Sunsaneewitayakul B; Yao Y; Thamaree S; Zhang S
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S10-6. PubMed ID: 22988965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal action potential duration restitution property in the right ventricular outflow tract in Brugada syndrome.
    Ashino S; Watanabe I; Kofune M; Nagashima K; Ohkubo K; Okumura Y; Nakai T; Kasamaki Y; Hirayama A
    Circ J; 2010 Apr; 74(4):664-70. PubMed ID: 20190424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.
    Doi A; Takagi M; Maeda K; Tatsumi H; Shimeno K; Yoshiyama M
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):688-96. PubMed ID: 20050961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome.
    Chinushi M; Komura S; Izumi D; Furushima H; Tanabe Y; Washizuka T; Aizawa Y
    Pacing Clin Electrophysiol; 2007 May; 30(5):662-71. PubMed ID: 17461877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Endocardial Ablation of Drug-Resistant Ventricular Fibrillation in Brugada Syndrome: Long-Term Outcome.
    Talib AK; Takagi M; Shimane A; Nakano M; Hayashi T; Okajima K; Kentaro M; Fukada K; Kowase S; Kurosaki K; Nitta J; Nishizaki M; Yui Y; Talib A; Sato N; Kawamura Y; Hasebe N; Aita S; Sai E; Komatsu Y; Kuroki K; Kaneshiro T; Dongzu X; Tajiri K; Igarashi M; Yamasaki H; Murakoshi N; Kumagai K; Sekiguchi Y; Nogami A; Aonuma K
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e005631. PubMed ID: 30354308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
    Nagase S; Kusano KF; Morita H; Nishii N; Banba K; Watanabe A; Hiramatsu S; Nakamura K; Sakuragi S; Ohe T
    J Am Coll Cardiol; 2008 Mar; 51(12):1154-61. PubMed ID: 18355652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation.
    Shimizu W; Aiba T; Kurita T; Kamakura S
    J Cardiovasc Electrophysiol; 2001 Dec; 12(12):1418-21. PubMed ID: 11798001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient with Overlap Syndrome due to the E1784K SCN5A Mutation.
    Hasebe H; Yokoya T; Murakoshi N; Kurebayashi N
    Intern Med; 2020 Jan; 59(1):83-87. PubMed ID: 31484910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Electrocardiographic Differences in Brugada Syndrome With Spontaneous or Drug-Induced Type 1 Electrocardiogram.
    Nagayama T; Nagase S; Kamakura T; Wada M; Ishibashi K; Inoue YY; Miyamoto K; Noda T; Aiba T; Takaki H; Sugimachi M; Shimizu W; Noguchi T; Yasuda S; Kamakura S; Kusano K
    Circ J; 2019 Feb; 83(3):532-539. PubMed ID: 30643106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocardial electrograms from the right ventricular outflow tract after induced ventricular fibrillation in patients with Brugada syndrome.
    Ohkubo K; Watanabe I; Takagi Y; Okumura Y; Ashino S; Kofune M; Kofune T; Shindo A; Sugimura H; Nakai T; Kunimoto S; Kasamaki Y; Saito S; Hirayama A
    Circ J; 2007 Aug; 71(8):1258-62. PubMed ID: 17652891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of electrocardiographic risk markers for the initial and recurrent episodes of ventricular fibrillation in patients with Brugada syndrome.
    Morita H; Watanabe A; Kawada S; Miyamoto M; Morimoto Y; Nakagawa K; Nishii N; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):107-114. PubMed ID: 28940628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient local changes in right ventricular monophasic action potentials due to ajmaline in a patient with Brugada Syndrome.
    Eckardt L; Kirchhof P; Johna R; Breithardt G; Borggrefe M; Haverkamp W
    J Cardiovasc Electrophysiol; 1999 Jul; 10(7):1010-5. PubMed ID: 10413381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.